Stuart Henderson retired from Deloitte at the end of May 2016 after almost 34 years at the pinnacle of the accountancy profession during which he audited and advised some of Cambridge’s greatest science & technology businesses. During his career, Stuart counts 37 leading firms for which he had acted as audit partner.
He had been partner at Arthur Andersen from 1992 to 2002, where he sat on the Andersen global life sciences team as head of emerging biotechnology and was latterly head of European healthcare and Life Sciences for Deloitte and also served on the global industry team for seven years between 2004 and 2011.
He has since become a director of biotech member organisation One Nucleus, and has also taken a non-executive director role with Oxford BioMedica plc, a leading gene and cell therapy company.
Sarah Brereton, Director, Limewash
01223 813 557